Search results for " BRACHYTHERAPY"

showing 4 items of 44 documents

SU-G-201-02: Application of RayStretch in Clinical Cases: A Calculation for Heterogeneity Corrections in LDR Permanent I-125 Prostate Brachytherapy

2016

Purpose: Tissue heterogeneities and calcifications have significant impact on the dosimetry of low energy brachytherapy (BT). RayStretch is an analytical algorithm developed in our institution to incorporate heterogeneity corrections in LDR prostate brachytherapy. The aim of this work is to study its application in clinical cases by comparing its predictions with the results obtained with TG-43 and Monte Carlo (MC) simulations. Methods: A clinical implant (71 I-125 seeds, 15 needles) from a real patient was considered. On this patient, different volumes with calcifications were considered. Its properties were evaluated in three ways by i) the Treatment planning system (TPS) (TG-43), ii) a M…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMonte Carlo methodBrachytherapyHigh densityGeneral MedicineIntraoperative ultrasoundmedicineDosimetryChristian ministryMedical physicsbusinessNuclear medicineRadiation treatment planningProstate brachytherapyMedical Physics
researchProduct

Towards clinical application of RayStretch for heterogeneity corrections in LDR permanent 125-I prostate brachytherapy

2017

Purpose RayStretch is a simple algorithm proposed for heterogeneity corrections in low-dose–rate brachytherapy. It is built on top of TG-43 consensus data, and it has been validated with Monte Carlo (MC) simulations. In this study, we take a real clinical prostate implant with 71 125I seeds as reference and we apply RayStretch to analyze its performance in worst-case scenarios. Methods and Materials To do so, we design two cases where large calcifications are located in the prostate lobules. RayStretch resilience under various calcification density values is also explored. Comparisons against MC calculations are performed. Results Dose–volume histogram–related parameters like prostate D90, …

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMonte Carlo methodBrachytherapyProstate implant030218 nuclear medicine & medical imagingIntraoperative ultrasound03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureOncologyPròstataProstate030220 oncology & carcinogenesismedicineDosimetryRadiology Nuclear Medicine and imagingMedical physicsRadiation treatment planningbusinessBraquiteràpiaProstate brachytherapy
researchProduct

The use of nomograms in LDR-HDR prostate brachytherapy

2011

Purpose: The common use of nomograms in Low Dose Rate (LDR) permanent prostate brachytherapy (BT) allows to estimate the number of seeds required for an implant. Independent dosimetry verification is recommended for each clinical dosimetry in BT. Also, nomograms can be useful for dose calculation quality assurance and they could be adapt ed to High Dose Rate (HDR). This work sets nomograms for LDR and HDR prostate-BT implants, which are applied to three different institutions that use different implant techniques. Material and methods: Patients treated throughout 2010 till April 2011 were considered for this study. This exam ple was chosen to be the representative of the latest implant tech…

medicine.medical_specialtygenetic structuresbusiness.industrymedicine.medical_treatmentlcsh:RBrachytherapylcsh:MedicinePermanent prostate brachytherapyquality assuranceNomogramprostate brachytherapyKermaOncologymedicineDosimetryOriginal ArticleRadiology Nuclear Medicine and imagingMedical physicsbusinessDose rateindependent verificationQuality assuranceProstate brachytherapynomogramsJournal of Contemporary Brachytherapy
researchProduct

Source strength determination in iridium-192 and cobalt-60 brachytherapy : A European survey on the level of agreement between clinical measurements …

2021

Background and purpose: Brachytherapy treatment outcomes depend on the accuracy of the delivered dose distribution, which is proportional to the reference air-kerma rate (RAKR). Current societal recommendations require the medical physicist to compare the measured RAKR values to the manufacturer source calibration certificate. The purpose of this work was to report agreement observed in current clinical practice in the European Union. Materials and methods: A European survey was performed for high- and pulsed-dose-rate (HDR and PDR) highenergy sources (Ir-192 and Co-60), to quantify observed RAKR differences. Medical physicists at eighteen hospitals from eight European countries were contac…

medicine.medical_specialtymedicine.medical_treatmentBrachytherapyTreatment outcomeBrachytherapyR895-920HDRDose distributionMedical physicistMedical physics. Medical radiology. Nuclear medicinePDRmedicinemedia_common.cataloged_instanceRadiology Nuclear Medicine and imagingMedical physicsOriginal Research ArticleEuropean unionRC254-282media_commonRadiationCobalt 60 brachytherapybusiness.industryRAKRNeoplasms. Tumors. Oncology. Including cancer and carcinogensCertificateSource strengthCalibrationRadiologi och bildbehandlingbusinessRAKR; Calibration; HDR; PDR; BrachytherapyRadiology Nuclear Medicine and Medical Imaging
researchProduct